Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based VP’ operating in the Health Care space. If you think a VP’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Arjun Purkayastha
Senior Vice President – eCommerce, Digital & Ventures of Reckitt
Arjun Purkayastha is a purpose driven leader with extensive global experience managing diverse businesses and multi-cultural teams at FTSE Top 10 and Fortune 100 companies – RB and P&G. He has a strong track record of building outperforming teams, iconic brands & innovative business models across 60+ countries having lived & worked in the UK, Singapore, South Korea and India. He currently leads eCommerce, CRM, digital, DNVB & start up ventures globally for RB with P&L, strategic and operational responsibility of all online channels & customers. He serves on the Board of Directors of 4 high growth, online focused companies – Pharmapacks.com (one of the largest and best 3P resellers on Amazon), Bombay Shaving Company (leading men’s wellness company in India), UpSpring (mom & baby products) and Healthily by Your.MD (AI powered self care). He is also an Investment Committee Member of Founders Factory & RB’s JV focused on Hygiene & Home start ups.
Follow Arjun Purkayastha:
About Reckitt: Reckitt Benckiser Group is a consumer goods company makes health, hygiene and home products.
Bruno Angelici
Executive VP of AstraZeneca
Bruno Angelici was appointed in 2007, current term until 2019. He was formerly Executive Vice President, Europe, Japan, Asia Pacific, Latin America, Middle East, and Africa of AstraZeneca Plc.
Follow Bruno Angelici:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
James Weatherall
VP, Data Science & AI, Research and Development of AstraZeneca
Jim Weatherall is Head of the Advanced Analytics Centre (AAC) at AstraZeneca, a department of approximately 30 clinical and health data scientists across three countries covering the disciplines of advanced statistics, scientific computing, and biomedical and health informatics. A particle physicist by training, Jim spent time as an academic researcher, before becoming a scientific software engineer consulting across a range of different industries, including the life sciences. He has had affiliate staff status at the University of Manchester since 2012, most recently being appointed as honorary reader at the University’s Health eResearch Centre. Jim and his team have introduced a number of innovations into the clinical research field, in areas such as data and text mining, data visualization, health technology evaluation, and clinical trial design.
Follow James Weatherall:
About AstraZeneca, University of Manchester: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Mark Cooper
Vice President and Managing Director, Avery Europe and Asia Pacific of CCL Industries
Mark Cooper is a Vice President and Managing Director, Avery Europe and Asia Pacific at CCL Industries.
Follow Mark Cooper:
About Avery, CCL Industries: CCL is the largest label company in the world and provides innovative solutions.
Jamie Robinson
Vice President and Managing Director, Home & Personal Care Europe of CCL Industries
Jamie Robinson is a Vice President and Managing Director, Home & Personal Care Europe at CCL Industries.
Follow Jamie Robinson:
About CCL Industries: CCL is the largest label company in the world and provides innovative solutions.
Mark Wenham
Executive Vice President of Multi Packaging Solutions
Mark Wenham was appointed to the position of Executive Vice-President at Multi Packaging Solutions in November 2014. Mark has responsibility for all European operations dedicated to the Healthcare market. Previously Mark served as managing director for Chesapeake’s UK, Ireland and Asia healthcare operations and has been with the company for 18 years. He has thorough understanding of the business through a variety of roles including responsibility for its Benelux sites and a management period in the U.S. A lithographic printer by training, Mark has worked for over 33 years in the print and packaging sector. During his tenure, Mark has directed the business through a period of strong growth and he has overseen an unprecedented investment program resulting in new equipment at every location.
Follow Mark Wenham:
About Multi Packaging Solutions: Multi Packaging Solutions provides packaging solutions for healthcare markets.
Jeanne Bolger
Vice President Venture Investing of Johnson & Johnson Development Corporation
Jeanne Bolger, MB BCh BAO, Vice President, Venture Investments, joined Johnson & Johnson Development Corporation (JJDC) in 2013. She is based in London, UK. Dr. Bolger has over 25 years of pharmaceutical industry experience in management roles across R&D, Commercial and Business Development (BD). She spent 11 years in Licensing and Acquisition (L&A), most recently as Global Head of Scientific Licensing for Johnson & Johnson’s Pharmaceutical business, having joined Johnson & Johnson in 2005 from the Business Development group at GlaxoSmithKline. In 2009, Dr. Bolger became Vice President, Alliance Management at Janssen Alzheimer Immunotherapy, working with Pfizer and Elan. Dr. Bolger received her medical degree from University College Dublin. She also holds diplomas in Child Health (NUI) and in Finance and Accounting (ACCA). She is a Fellow of the Royal Academy of Medicine of Ireland (RAMI). Dr. Bolger has served as the sole pharma industry representative on two Irish government taskforces seeking to enhance the commercialization of IP from Irish academic centres. She is a visiting lecturer on the MSc Pharmaceutical Medicine curriculum at Trinity College in Dublin, Ireland.
Follow Jeanne Bolger:
About Johnson & Johnson Development Corporation, Pulmocide: Johnson & Johnson Development Corporation, a venture capital subsidiary, finances technology companies focused on patient health.
Victoria Kitcatt
Vice President and Assistant General Counsel of Pfizer
Follow Victoria Kitcatt:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Jenny Laird
VP, Search & Evaluation – Neuroscience of Eli Lilly
Follow Jenny Laird:
About Eli Lilly: Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Stella Blackburn
VP, Global Head of Early Access & Risk Management & Real World Evidence Solutions of IQVIA
Follow Stella Blackburn:
About IQVIA, London School of Hygiene & Tropical Medicine: IQVIA is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry.
Tom Eilon
VP Strategy of AccuRx
Follow Tom Eilon:
About AccuRx, Founders Academy: AccuRx is on a mission to bring patients and their healthcare teams together.
Fred Reno
VP of Toxicology & Consultant of Spinifex Pharmaceuticals
During his over 40 years career in the pharmaceutical and biotechnology sectors, Fred has provided scientific expertise in the areas of toxicology, preclinical aspects of drug and device development, strategies for product safety evaluation, and liaison with appropriate regulatory agencies. His experience includes; organizing and directing safety evaluation programs and interfacing with contract laboratories; providing scientific opinions on toxicology aspects of potential candidate compounds for licensing; and preparation of preclinical summariesfor U.S. (IND, NDA, IDE, PMA) and foreign pharmaceutical submissions. Working together with Colleen Johnson, Fred has led the IND enabling and subsequent toxicology program for EMA401. Fred has Ph.D., Toxicology from Utah State University, M.S., Zoology from University of Nevada and B.S., Biology from University of San Francisco.
Follow Fred Reno:
About Spinifex Pharmaceuticals: Spinifex Pharmaceuticals is a clinical-stage biotechnology company specializing in the development of products for the treatment of pain.
John Wigneswaran
Vice President of Clinical Affairs of DaVita
Follow John Wigneswaran:
About DaVita: DaVita is a provider focused on transforming care delivery to improve quality of life for patients globally.
Phillip Duncan
SVP Global Procurement of McKesson
Follow Phillip Duncan:
About McKesson: McKesson distributes medical supplies, information technology, and care management products and services.
Ben Heubl
VP Europe of MedStartr
Ben is our EU Lead, advancing the MedStartr Model into Europe. A well-connected, avid networker with mad marketing skills AND is fluent in six languages, Ben is the “full package” and a perfect fit for the EU Lead role. Ben’s ability to forge collaborations, his experience, and knowledge in EU regulatory strategy aid his efforts. He also has been actively building out a Health Innovation Ecosystem in Europe, not only starting Health 2.0 Copenhagen, but also acting as a mentor for the Kairos Society K50, HealthXL StartupBootcamp Accelerator, and organizing TEDMED live events. Prior to MedStartr, Ben co-founded a health-tech startup while at Lund University and worked as a consultant for ICG. Ben has been innovating and creating a vibrant health innovation ecosystem in Europe and beyond and we are very pleased that he has chosen the MedStartr model for the next stage of his efforts. “My goal is to work and collaborate with partners and like-minded people to create and implement innovation, facilitate great innovation concepts and contribute value in successful and exciting companies that drive positive change for societies and create a better place for all of us.” – Ben
Follow Ben Heubl:
About Institution of Engineering and Technology, MedStartr: MedStartr is a crowdfunding platform designed for the healthcare industry.
Disa Sanstorn
Senior Vice President Business Development Europe of YgEia3
Follow Disa Sanstorn:
About YgEia3: YgEia3 works with corporations developing comprehensive wellness testing for each company.
Vincent Miceli
Vice President & Chief Financial Officer of NXT-ID
Vincent Miceli, age 56, has extensive hands on experience in financial and operational management and business leadership in both substantial private and public companies. He is also experienced with working with public company Boards of Directors, as well as financial institutions. Vincent Miceli was the Vice-President and Chief Financial Officer/Treasurer of Panolam Industries International, Inc., a company which primarily designs, manufactures and distributes decorative and industrial laminates, from May 2006 to mid-December 2013. Prior to that, Vincent Miceli was the Chief Financial Officer and Corporate Controller of Opticare Health Systems, Inc., a public company which provides integrated eye care services, from 2004 to 2006. Prior to 2004, Vincent Miceli held senior accounting positions at Amphenol Corporation and United Technologies, Inc. Vincent Miceli holds a BS in accounting from Quinnipiac College, an MBA, with a concentration in Finance, from the University of Hartfordand he is an affiliate member of both the AICPA and the CT Society of Certified Public Accountants.
Follow Vincent Miceli:
About NXT-ID: Sensor, Mobile, HealthTech, MedTech
Zeshan Ghory
VP of Operations & Analytics of Antidote.me
Follow Zeshan Ghory:
About Antidote.me: Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Andrew Lonergan
VP Sales and Marketing of Aspect Imaging
Follow Andrew Lonergan:
About Aspect Imaging: World leader in the design and manufacture of compact, high-performance MRI & NMR systems offering Complete Point-of-Care MRI systems
Kristina Kaganer
Global VP, Commerce Data Products and Analytics of Coty
Follow Kristina Kaganer:
About Coty: Coty Inc is a New York based beauty company with portfolios in fragrance, color cosmetics and skin care.
Paul Lyons
Vice President of Platform Delivery & Co-Founder of PredictImmune
Paul is a Principal Research Associate in the Department of Medicine at the University of Cambridge. He has over 25 years of experience in molecular and cellular biology including Senior Scientist positions in the Dept. Medical Genetics, University of Cambridge, Dept. Surgery, University of Oxford and the Rosalind Franklin Centre for Genomics Research. His primary research interest is the application of high throughput genomic approaches to better understand the genetic and molecular basis of autoimmune disease.
Follow Paul Lyons:
About PredictImmune: Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Colin Hutchison
Vice President of International of Edgewell Personal Care
Colin joined Energizer in 2004 as Vice President Europe for Wilkinson Sword. In 2006 he led the successful integration of the Personal Care and Household Divisions in Europe. After the Playtex acquisition, he became Vice President for Personal Care in Europe and led planning for the distribution expansion of Hawaiian Tropic and the Hydro brand launch. After the American Safety Razor acquisition, Colin was appointed Vice President and General Manager for EPC’s Private Brands Group. Overseeing strategic development for the global private label wet shave business, he reshaped the portfolio and developed a roadmap for growth through NPD and distribution expansion. Additionally, he led the integration of most functions into the wider Personal Care business structures. Prior to Edgewell, Colin worked for a number of consumer goods businesses based in Europe including United Biscuits and the Campbell’s Soup Company. He held various positions in sales, marketing, and general management that latterly included international responsibilities.
Follow Colin Hutchison:
About Edgewell Personal Care, Energizer Holdings: Edgewell Personal Care manufactures and markets a diversified range of personal care products.
Paul Grabscheid
Vice President of Strategic Planning of Intersystems
Since 1986, Paul Grabscheid has used his expertise in database and application development tools and technologies in a variety of product planning and marketing roles at InterSystems. Prior to that, he served as director of marketing for Mathematica, a database and 4GL software company, helping to expand the company’s worldwide presence. When the company was acquired by Martin Marietta he served as director of marketing for that firm’s Information Technology Division, overseeing marketing efforts for a number of system software, application software, and computer services product lines. Grabscheid’s background also includes consulting work involving the development of decision support systems for state governments. He holds a master’s degree from the Sloan School of Management at the Massachusetts Institute of Technology.
Follow Paul Grabscheid:
About Intersystems: InterSystems is a vendor of software and technology for high-performance database management, integration, and health information systems.
Ricky Patel
VP Engineering of Lumeon
Ricky Patel is VP of Engineering at Lumeon.
Follow Ricky Patel:
About Lumeon: Lumeon is a digital health company providing management care solutions to the healthcare industry.
Jeffrey Ball
VP of Customer Satisfaction of Lumeon
Jeff is an experienced customer success strategist, with over sixteen years’ experience growing operational, sales and service line departments within start-up and enterprise environments. He has extensive experience in the Telcoms, SaaS and IT consultancy sector, having held the position of Director of Service Operations at companies including PassivSystems, Affinity, Viatel and RSL COM. Jeff was also Head of National Service Centre for Volkswagen Group, where he headed a team of over 300 people, helping the company achieve the highest possible quality scores as rated by the automobile industry.
Follow Jeffrey Ball:
About Lumeon: Lumeon is a digital health company providing management care solutions to the healthcare industry.
Rebecca Matthews
VP Marketing of Koru Kids
Follow Rebecca Matthews:
About Koru Kids: Koru Kids is a building better childcare services, starting with nanny sharing in London.
Simon Viggers
Vice President Human Resources of Otsuka Pharmaceuticals
Simon Thule Viggers is a Senior HR Leader with deep global experience. Almost 20 years of experience within Pharma, 15 years in leadership roles across three continents. Proven ability to lead through challenging change and with an ability to approach business in a holistic way. Simon takes the starting point in the business agenda and translates that into actions for the organization and the people. Simon has a strong leadership background as he has been part of executive teams for more than a decade and has been preferred coach to many executives.
Follow Simon Viggers:
About Otsuka Pharmaceuticals: Otsuka Pharmaceuticals is a pharmaceutical company that operates throughout the globe.
Gareth Ridge
Senior Vice President of Operations & Site Head of Cambridge Epigenetix
Gareth has a degree in Pharmacology from the University of Cambridge and has worked in the pharmaceutical sector for over 20 years. During his career he has worked for both large and small pharma, biotechnology and clinical research organisations, he also has five years’ experience in business consultancy. In addition to delivering successful clinical research projects Gareth has managed business change projects – including system implementations, process reengineering and organisational change. He has held many leadership positions with responsibility for project and revenue delivery and strategic growth and has had oversight of over 70 clinical research studies, either directly as project manager or as responsible head, and has worked in high growth companies where he successfully built a team to successfully deliver 700% growth in project delivery & revenue in 2 years.
Follow Gareth Ridge:
About Cambridge Epigenetix: Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Joanna Holbrook
Senior Vice President of Research of Cambridge Epigenetix
Joanna started her career in GSK R&D, working for seven years in the UK bioinformatics department, processing the integrating ‘omic data for drug target identification and validation mostly focussing on neurological disease, and then for three years in GSK USA Oncology R&D working on biomarkers for targeted therapies. She then left GSK and the USA for Singapore and built an academic group in A*STAR Singapore Institute for Clinical Sciences. Her group focused on epigenomic trackers of complex disease, especially the interaction of genetic, environmental and disease states in shaping the human epigenome. Her work in Singapore encompassed set-up of observational and interventional cohorts, biobanking, clinical databases, production, processing and analysis of biosample ‘omic profiles and multiple industrial collaborations. Moving back to the UK five years later, she took up a professorship at the University of Southampton, still working on epigenomics and also integration of electronic health record data to clinical cohorts. Most recently she has been VP of Translational Medicine at BenevolentAI, a fast growing British Biotech, where she initiated and led integration of ‘omic data into a large biomedical knowledge graph and machine learning approaches to analyses of patient-level data for precision medicine.
Follow Joanna Holbrook:
About Cambridge Epigenetix: Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Kurt Kelln
EVP of Sales and Marketing, CBO of SuperSonic Imagine
Kurt Kelln has lived and worked in the USA, Germany and the UK and has an extensive knowledge of the International Healthcare Markets. In addition, Mr. Kelln possesses a wealth of experience in the field of ultrasound imaging, a domain he has worked in for more than 25 years. Prior to joining SuperSonic Imagine in April 2012, Mr. Kelln served as Vice President of Ultrasound and Women’s Healthcare at Philips Healthcare where he implemented successful sales and marketing strategies for mature and growth markets. He was responsible for leading one of the largest and most successful sales and marketing teams in the industry. Before Philips, Mr. Kelln spent 11 years with ATL Ultrasound in various strategic leadership positions in Operations, Administration, Sales and Marketing. He has vast experience in business strategy, sales and marketing leadership, and general management.
Follow Kurt Kelln:
About SuperSonic Imagine: SuperSonic Imagine develops and manufactures ultrasound medical imaging systems for evaluating and visualizing tissue elasticity.
Patrick Darby
Executive Vice President, General Counsel & Corporate Secretary of Encompass Health Corp.
Patrick Darby was named executive vice president, general counsel and corporate secretary of HealthSouth in February 2016. Prior to joining us, Darby was a partner of the law firm of Bradley Arant Boult Cummings LLP, in Birmingham, Alabama. He is listed in Chambers USA, The Best Lawyers in America and Alabama Super Lawyers. He received his bachelor’s degree from Dartmouth College and his law degree from Washington & Lee University School of Law, where he was editor-in-chief of the Washington & Lee Law Review.
Follow Patrick Darby:
About Encompass Health Corp.: Encompass Health Corp. (HealthSouth), is an owner and operator of inpatient rehabilitation hospitals.
Clare Cooper
Founder and Vice President of Storm3
Clare Cooper is the Founder and Vice President at Storm3.
Follow Clare Cooper:
About Storm3: Storm3 are a global HealthTech talent marketplace, connecting organizations with the talent to drive their mission.
William Richardson
Executive Vice President of Savaria Corp
Follow William Richardson:
About Savaria Corp: Savaria provides accessibility solutions for the elderly and physically challenged to increase their mobility and independence.
Richard Lagani
Executive Vice President of MMRGlobal
Richard Lagani is an Senior Management Professional
Follow Richard Lagani:
About MMRGlobal, MMRGlobal: MMRGlobal provides secure, easy-to-use multilingual personal health records (PHRs) and electronic safe deposit box storage solutions.
Nick Child
Vice President of Stablepharma Ltd
Nick Child – Vice President & Co Founder Experienced company leader, business developer, multi-disciplined & experienced in UK & International markets, manufacturing & distribution. Initiated various start-ups, acquisitions, & funding rounds.
Follow Nick Child:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Paul Marcun
Executive Vice President, Chronic Care of Coloplast Denmark
Paul Marcun is the Executive Vice President of Chronic Care at Coloplast.
Follow Paul Marcun:
About Coloplast Denmark: Coloplast is a Danish company that develops and markets products and services related to ostomy, urology, continence, and wound care.
Alastair Macdonald
SVP, Real World and Late Phase of Syneos Health
Alastair MacDonald, Executive Director, Real World & Late Phase, has 25 years of experience in the biopharmaceutical development sector. Prior to joining INC, he was Global Delivery Director for Medical Evidence and Observational Research at Astra Zeneca with responsibility for the generation of evidence in both pre- and post-approval drugs required to support core clinical development programs and prepare for reimbursement.
Follow Alastair Macdonald:
About Syneos Health: Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization.
Keith Sturges
Senior Vice President International & Marketing of Sunquest Information Systems
With more than 20 years of global leadership experience in software and services companies, Keith leads Sunquest’s international business focused on extending the Sunquest brand and solutions to healthcare organizations across the world. Prior to joining Sunquest, Keith served as executive vice president of sales and implementation for Craneware, a provider of healthcare revenue cycle management tools. He has also held executive leadership positions with SirsiDynix International, Homecare Systems at Misys PLC, Allscripts Healthcare Solutions, Inc. (formerly, Allscripts-Misys Healthcare Solutions Inc., Misys Healthcare Systems LLC) and Oracle. Keith holds a Master’s of Business Administration and Computer Science from the University of Warwick in the United Kingdom.
Follow Keith Sturges:
About Sunquest Information Systems: Sunquest is the market leader in the laboratory. Sunquest Information Systems, Inc.
Bryan Olin
Senior Vice President of LivaNova
Bryan Olin, PhD is the Senior Vice President, Clinical, Quality & Regulatory Affairs at LivaNova. Dr. Olin joined Cyberonics in May 2009 as Vice President, Quality. In August 2009, he assumed additional responsibility for Clinical Affairs, and in April 2011, his responsibilities were expanded again to include Regulatory Affairs. With the 2015 merger between Cyberonics and Sorin, his responsibilities expanded to include corporate-wide responsibilities for the clinical, quality and regulatory affairs functions at LivaNova. Prior to May 2009, Dr. Olin was employed at Zeltiq Aesthetics, Inc., a privately held medical technology company in the San Francisco area, where he served as Sr. Director, Quality Assurance since October 2007. Prior to Zeltiq Aesthetics, Dr. Olin was employed at the LifeScan and Cordis companies of Johnson & Johnson from 1999 to 2007, holding several positions of increasing responsibility in quality assurance, statistics and clinical data management. Dr. Olin began his career with Procter & Gamble in 1993 after obtaining his Ph.D. in Statistics from Iowa State University. He currently serves on the board of directors for the Medical Devices Innovation Consortium (MDIC) and as an industry representative on the Advisory Committee for The National Patient-Centered Clinical Research Network (PCORnet).
Follow Bryan Olin:
About LivaNova: LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment.
Valerie Morisset
Co-Founder, EVP of R&D, and CSO of Eliem Therapeutics
Valerie Morisset is the Co-Founder, EVP of R&D, and CSO at Eliem Therapeutics.
Follow Valerie Morisset:
About Eliem Therapeutics: Eliem Therapeutics is a clinical-stage biotechnology company developing treatments for nervous system disorders.
Melany Pierson
VP Business Development of HCA International
Follow Melany Pierson:
About HCA International: HCA is one of the nation’s leading providers of healthcare services.
Caroline Stockwell
VP, Head of Legal International of Intercept Pharmaceuticals
Follow Caroline Stockwell:
About Intercept Pharmaceuticals: Intercept Pharmaceuticals develops small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases.
Christian Barnett
SVP Strategy of ReviveHealth
Follow Christian Barnett:
About ReviveHealth: ReviveHealth is a full-service agency focused on the intersection of healthcare delivery, finance, and innovation.
Kim Fieldbinder
Executive Vice President & Chief Financial Officer of SourceMedical-TherapySource
Kim Fieldbinder joined SourceMed as a senior accountant in August of 2001 and is currently the Company’s Executive Vice President and Chief Financial and Administrative Officer. Recently, Kim was named to the Birmingham Business Journal’s prestigious Top 40 Under 40 list for her impressive contributions to the area’s business industry and her work with SourceMed. During her time with the company, Kim has not only paved the way for female leaders as the first woman to be made a SourceMed executive, but has also helped create a leadership training and mentoring program to provide guidance and advisement to up-and-coming employees and the company’s first corporate giving program, Source Cares, which focuses on bringing hope to pediatric cancer patients. Prior to joining SourceMed, Kim was a senior accountant at Ernst & Young, LLP where she assisted in the financial audits of public companies. Kim is a certified public accountant and holds a Bachelor’s degree in accounting from the University of Alabama at Birmingham as well as a Master’s degree in accounting from the University of Alabama. Kim has been in the Birmingham market for over 18 years. She engages projects with intensity and a commitment to excellence. Kim is a team builder, facilitator, and problem- solver who propels companies forward. She resides in Birmingham with her husband and their son and spends her free time serving on the boards of many local charities.
Follow Kim Fieldbinder:
About Randall-Reilly, SourceMedical-TherapySource: SourceMedical-TherapySource provider of outpatient information solutions.
Daniel Barnett
MD Ireland and VP Primary Care Service Delivery UK of HealthHero
Follow Daniel Barnett:
About HealthHero: HealthHero offers remote access to experienced doctors and expert clinicians directly to patients, insurance-policy holders and employees.
Stephen Langlois
Vice President of Actuarial of Coverys
Steve Langlois has been with Coverys since 1989 and manages the actuarial function for the entire organization as the vice president of actuarial. Langlois first joined the organization as an underwriting assistant and has worked as an underwriter, a statistical analyst and actuarial analyst during his tenure with Coverys. Langlois received a Bachelor of Arts degree in mathematics from Boston College and an associate degree in underwriting designation from the Insurance Institute of America.
Follow Stephen Langlois:
About Coverys: Coverys is a provider of medical professional liability insurance for physicians, hospitals, dentists and advanced practice providers.
Stephen Langlois
Vice President of Actuarial of Coverys
Steve Langlois has been with Coverys since 1989 and manages the actuarial function for the entire organization as the vice president of actuarial. Langlois first joined the organization as an underwriting assistant and has worked as an underwriter, a statistical analyst and actuarial analyst during his tenure with Coverys. Langlois received a Bachelor of Arts degree in mathematics from Boston College and an associate degree in underwriting designation from the Insurance Institute of America.
Follow Stephen Langlois:
About Coverys: Coverys is a provider of medical professional liability insurance for physicians, hospitals, dentists and advanced practice providers.
Tony Brown
Vice President of Scientific and Corporate Development of Asterand
Tony has been with Asterand Bioscience for 16 years. Prior to taking up his current position, he held a number of senior positions within the company including General Manager for the UK Services business, General Manager for the Detroit-based tissue products business and VP, Strategic Alliances, with responsibility for securing and managing the Company’s human tissue supply collaborations. Tony began his career teaching physiology at Nottingham University Medical School in the UK, after obtaining degrees in engineering, bioengineering and a PhD in physiology. He subsequently joined SmithKline Beecham in 1988, where he headed up the receptor pharmacology group within neurosciences research, and led several drug discovery projects and drug screening programs. Tony joined Pharmagene (now Asterand Bioscience) in 1998. Tony has published on the pharmacology and biochemistry of ion and neurotransmitter transport and on the use of human tissues for research in drug discovery and development.
Follow Tony Brown:
About Asterand: Asterand Bioscience is the leading global provider of high quality, well characterized human tissue & human tissue-based research solution.
Katie Bettell Higgins
VP Customer Success of Patients Know Best
Katie qualified as a nurse in 1997. She started her career in orthopaedics and trauma becoming a clinical Nurse specialist focusing on spinal injury and surgery. She also lectured on the spine to postgraduate nurses at the Florence Nightingale School, Kings College London. Later, she worked as a school nurse in East London and whilst in this role was nominated for an Innovation in Practice award for her work in improving sex and relationship education for 10 and 11 year olds. Katie also worked as a specialist practitioner in contraceptive and sexual / reproductive health for many years. As both a CNS and a school nurse Katie experienced first hand the frustration of being unable to communicate easily and effectively with other professionals in the patient’s circle of care and the impact of this on the patient. As the mother of 3 young children, one of which spent prolonged time in the healthcare and hospital system she has also experienced the frustration of trying to coordinate such fragmented communication from the patient perspective.
Follow Katie Bettell Higgins:
About Patients Know Best: Patients Know Best provide hospitals with personal health records software so that their patients can better manage their health.
Brad Bailey
Vice President of Sales of Ivy Sports Medicine
Brad Bailey, Vice President of Sales brings over 19 years of experience in the medical device industry with a focus in Sales management and Marketing. He has extensive experience in building teams to execute sucessful product launches and realize sustained sales growth. Mr. Bailey has worked in and run sales organizations focusing in Sports Medicine, he was Director of Sales of the Sports Tissue and Biologics Division at ConMed Corportation. He has also held leadership positions with the Musculoskeletal Transplant Foundation (MTF), DePuy Spine and Spar Medical. Mr. Bailey graduated from Birmingham Southern College in 1993 with a B.S. in Management.
Follow Brad Bailey:
About Ivy Sports Medicine: Ivy Sports Medicine is a young, dynamic company with extensive expertise in the development and production of meniscus implants.
Douglas Anderson
Founder & Vice President of Global Advocacy of Optos
Founder & Vice President of Global Advocacy, Optos plc, Douglas has a 35 year business career yielding huge experience in almost every aspect, and at every level, of healthcare technology development and commercialisation; initially as a highly creative hands-on designer, then as a design manager and technology innovator, transitioning through sales and marketing, and finally into business leadership as a serial entrepreneur.
Follow Douglas Anderson:
About Optos: Optos operates as a medical retinal imaging company.
Robert Spavin
Vice President of Legal Affairs of Virttu Biologics
Robert joined VIRTTU in 2003 as Legal Counsel responsible for the company’s legal and intellectual property affairs. Qualifying as a solicitor with City of London firm Herbert Smith in 1996, he subsequently specialised in IP law at leading IP firm Bird & Bird. He is experienced in the development of growth technology companies, patent management and regulatory affairs.
Follow Robert Spavin:
About Virttu Biologics: Virttu is a privately held biotechnology company, which has pioneered the development of oncolytic viruses for treating cancer.
Alex Graham
Vice President of Translational Medicine of Virttu Biologics
Dr. Alex Graham has more than 30 years of experience as a scientist in the biotechnology and pharmaceutical sector, having most recently worked as a Principal Scientist for AstraZeneca. He has led several small molecule discovery projects and most recently was responsible for the Genomics Facility for AstraZeneca Oncology. He was also responsible for introducing relevant new technologies into the Oncology business, specifically in the areas of biomarkers and translational medicine. Alex joined Virttu in 2008 and has been closely involved in the planning,management and analysis of Virttu’s clinical studies.
Follow Alex Graham:
About Virttu Biologics: Virttu is a privately held biotechnology company, which has pioneered the development of oncolytic viruses for treating cancer.
Robin Marriott
Co-Founder and Executive Vice President of Pharmaceutical Development of PowderMed
PowderMed at Co-Founder.
Follow Robin Marriott:
About PowderMed: PowderMed developed the Particle Mediated Epidermal Delivery (PMED) technology.
Jerome Declerck
Vice President Research & Develop,ment of Optellum
Follow Jerome Declerck:
About Optellum: Optellum develops an imaging biomarker for smart lung cancer detection.
Nicholas Lakin
Vice President, Advisory Services of Kinapse
Follow Nicholas Lakin:
About Kinapse: Kinapse provides advisory, capability building and operational services to the life sciences industries.
